{"id":"W2103134643","doi":"10.1200/jco.2004.06.075","title":"Multicenter Phase II Study of Erlotinib, an Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck","year":2003,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":808,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Erlotinib; Rash; Internal medicine; Tolerability; Epidermal growth factor receptor; Mucositis; Oncology; Head and neck cancer; EGFR inhibitors; Population; Erlotinib Hydrochloride; Phases of clinical research; Gastroenterology; Cancer; Adverse effect; Toxicity","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001055865,0.0001762125,0.001766214,0.00009770079,0.00005127725,0.000002705587,0.0001018248,0.00009598512,0.0001126694],"category_scores_gemma":[0.00217068,0.00008651295,0.0001327363,0.0002067752,0.00023419,0.0001112629,0.00005418718,0.0006114028,2.644705e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009597719,"about_ca_system_score_gemma":0.000840446,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001372212,"about_ca_topic_score_gemma":0.001306281,"domain_scores_codex":[0.9961535,0.0008746942,0.002143125,0.0002048567,0.0003982419,0.0002255777],"domain_scores_gemma":[0.9967098,0.0007806105,0.001514719,0.0001612099,0.0005873284,0.0002463352],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0380232,0.05304797,0.8748075,0.000142989,0.0001755454,0.00004903256,0.001952719,0.000003576543,0.0001680353,0.000002149072,0.0003703084,0.03125693],"study_design_scores_gemma":[0.0885061,0.2288841,0.6790468,0.0003068589,0.0003997936,0.000005912708,0.0007461074,0.00001260167,0.0006730058,0.00000236844,0.001321774,0.00009463749],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9973692,0.0004017921,0.000001809649,0.0005739785,0.000860905,0.0007259286,0.00002755529,0.000002194591,0.00003661569],"genre_scores_gemma":[0.9984617,0.0001557775,0.0008541793,0.0003632166,0.0001066129,0.000009372234,9.823101e-7,0.00001584179,0.00003237653],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1957608,"threshold_uncertainty_score":0.3527896,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1174694466171304,"score_gpt":0.4563328035458323,"score_spread":0.3388633569287018,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}